Skip to main content
OpenTrials

Clinical trial condition

Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker)

Explore clinical trials studying Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker) trial results

Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

NCT05475925

Conditions
Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
Locations
  • Dren Investigational Site Birmingham, Alabama, United States
  • Dren Investigational Site Duarte, California, United States
  • Dren Investigational Site Irvine, California, United States
  • Dren Investigational Site Redwood City, California, United States
View all 37 locations
View Trial Details

Related conditions